Clinical Trial Update: Intranasal Ketamine and Fracture Reduction in Pediatric Emergencies (KETAPED) [Phase 3]

View source ↗

Summary

Phase 3 trial update for intranasal ketamine in pediatric fracture reduction (KETAPED) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fractures Closed

Drugs mentioned

• Intranasal ketamine (ketamine)

Snippet

Sponsor: Fondation Lenval | Conditions: Fractures, Closed | Phase 3 | Status: COMPLETED